Associated Papers
The phosphorylation state of both hERG and KvLQT1 mediates protein-protein interactions between these complementary cardiac potassium channel alpha subunits.
Popescu MC et al.
Biochimica Et Biophysica Acta. Biomembranes, 2021
Identification of small-molecule ion channel modulators in C. elegans channelopathy models.
Jiang Q et al.
Nature Communications, 2018
Ion channel phosphorylopathy: a link between genomic variation and human disease.
Gentile S
Chemmedchem, 2012
Long QT2 mutation on the Kv11.1 ion channel inhibits current activity by ablating a protein kinase Cα consensus site.
Donovan AJ et al.
Molecular Pharmacology, 2012
Mechanisms underlying the protein-kinase mediated regulation of the HERG potassium channel synthesis.
Krishnan Y et al.
Biochimica Et Biophysica Acta, 2012
Upregulation of HERG channels by the serum and glucocorticoid inducible kinase isoform SGK3.
Maier G et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2006
Pharmacology of cardiac potassium channels.
Tamargo J et al.
Cardiovascular Research, 2004
14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity.
Kagan A et al.
The Embo Journal, 2002
Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A.
Thomas D et al.
The Journal of Biological Chemistry, 1999
Select a paper to view details